18 May 2013
Keywords: fda, accepts, nda, watson, oab, gel, usa
Article | 09 June 2008
The USA's Watson Pharmaceuticals says that its New Drug Application for oxybutynin chloride topical gel has been accepted for filing ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2008
17 May 2013
© 2013 thepharmaletter.com